Showing results (111-120 of 4,868) with videos related to

Sort By:
Pageof 487
Urologic Oncology|June 18, 2017
Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the synchronous metastatic and elderly populationsMagnus Lindskog, Thomas Wahlgren, Rickard Sandin, et al.
Urologic Oncology|June 6, 2017
Subclassification of pN3 staging systems for penile cancer: Proposal for modification of the current TNM classificationZhiyong Li, Shengjie Guo, Zhiming Wu, et al.
Urologic Oncology|June 6, 2017
Optimizing management of upper tract urothelial carcinomaMatthew T Campbell, Amishi Y Shah, Surena F Matin, et al.
Urologic Oncology|October 24, 2021
Assessing the diagnostic performance of systematic freehand PrecisionPoint transperineal prostate biopsy: Comparison of observed outcomes to PBCG nomogram predictionsShaan Setia, Jamaal Jackson, Demetri Cendo, et al.
Urologic Oncology|February 11, 2022
Stereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombusYuval Freifeld, Ivan Pedrosa, Mark Mclaughlin, et al.
Urologic Oncology|February 12, 2022
Novel plasma glycoprotein biomarkers predict progression-free survival in surgically resected clear cell renal cell carcinomaDaniel J Serie, Amanda A Myers, Daniela A Haehn, et al.
Urologic Oncology|October 8, 2021
Development and validation of a nomogram to predict postoperative cancer-specific survival of patients with nonmetastatic T3a renal cell carcinomaPengju Guo, Yongxing Wang, Yili Han, et al.
Urologic Oncology|October 11, 2021
Clinical indications for necessary and discretionary hospital readmissions after radical cystectomyAhmet Murat Aydin, Richard R Reich, Biwei Cao, et al.
Urologic Oncology|February 9, 2022
Uptake of re-resection in T1 bladder cancer: An interrupted population-based time series analysis among different groups of surgeonsMarian S Wettstein, Nancy N Baxter, Rinku Sutradhar, et al.
Urologic Oncology|July 28, 2022
Significance of metabolic tumor volume and total lesion uptake measured using Ga-68 labelled prostate-specific membrane antigen PET/CT in primary staging of prostate cancerEralp Kubilay, Çaǧrı Akpinar, Efe Semetey Oǧuz, et al.
Pageof 487